Introduction {#sec1-1}
============

Hearing loss is a functional disability which affects a person\'s day-to-day activities in subtle ways. Sensorineural hearing loss involving the inner ear and its central connections is irreversible. The prevalence of hearing loss in diabetes has been shown in many studies\[[@CIT1]--[@CIT11]\] to be moderately high, progressive and bilateral. The predominant mechanism of hearing loss in diabetes appears to be related to microangiopathy of the inner ear.\[[@CIT12]\] The prevalence of hearing loss in diabetics in Indian population has not been studied extensively.\[[@CIT7]\]

The present study is undertaken to compare auditory acuity in normoglycemic and hyperglycemic subjects to find out the effect of hyperglycemia on auditory acuity.

Diagnostic audiometry comprises tests that detect conductive and sensorineural hearing losses. Pure tone audiometry involves the estimation of the threshold of hearing for certain standardized stimuli via the air and bone conduction routes.\[[@CIT13]\] An audiometer, being a fundamental tool in the diagnosis of auditory capacities, has been employed in this study.

Aim of the study {#sec2-1}
----------------

To assess the degree of auditory acuity in type 2 diabetes mellitus patients using pure tone audiometry \[evaluating the frequency and intensity of hearing acuity\]To compare pure tone audiometric results between diabetic type 2 patients \[hyperglycemic group\] and a matched control group \[normoglycemic group\].

Objectives of the study {#sec2-2}
-----------------------

To record pure tone audiometry in normoglycemic subjects.To record pure tone audiometry in hyperglycemic subjectsTo make a comparative study of the auditory acuity of type 2 diabetics and normoglycemic subjects.To analyze the effect of age, glycemic status (FBS, PPBS), glycemic control (HbA1C), duration of type 2 diabetes on auditory acuity.

Materials and Methods {#sec1-2}
=====================

Source of data {#sec2-3}
--------------

The study was conducted in a sample of 82 subjects in Bangalore. The study was approved by the institutional ethics committee of Bangalore Medical College and Rajiv Gandhi University of Health Sciences, Bangalore, India. They have been divided into two groups of 41 subjects each.

Group 1 comprises of 41 normal, healthy subjects of either sex selected from the patient attenders in Victoria hospital belonging to the ages between 35 and 55 years. Group 2 comprises of 41 type 2 diabetic patients of either sex selected from the Department of Medicine Victoria Hospital, belonging to the ages between 35 and 55 years. The sample size was determined after taking into consideration the methods used in other studies. Many published studies on the prevalence of hearing loss in diabetics used a similar sample size between 20 and 45 diabetic subjects.\[[@CIT1][@CIT3][@CIT6][@CIT7][@CIT10][@CIT11]\]

Method of collection of data {#sec2-4}
----------------------------

The study comprising of 41 type 2 diabetics and 41 nondiabetics, matched with respect to age and sex are selected based on inclusion and exclusion criteria.

Inclusion criteria \[group 1\] {#sec2-5}
------------------------------

Forty-one normal healthy subjects of either sex between 35 and 55 years who had given written consent and who were nonhypertensive were included.

Inclusion criteria \[group 2\] {#sec2-6}
------------------------------

Forty-one type 2 diabetic patients between the ages 35 and 55 years who had given written consent and who were nonhypertensive were included. Both groups were matched with respect to age and sex.

Exclusion criteria \[group 1\] {#sec2-7}
------------------------------

HypertensionDiabetes mellitusHistory of consumption of ototoxic drugs in past three months.History of ear surgeries performed in the past.History of ear infections in the past.History of recent infections in the nose, throat or ear.Patients having a noise induced hearing loss (as shown by pure tone audiometry at 4000 Hz.)

Exclusion criteria \[group 2\] {#sec2-8}
------------------------------

History of consumption of ototoxic drugs in past three months.History of ear surgeries performed in the past.History of ear infections in the past.History of recent infections in the nose, throat or ear.Patients having a noise induced hearing loss (as shown by pure tone audiometry at 4000 Hz.)

Pure tone audiometer {#sec2-9}
--------------------

### Instrument: {#sec3-1}

ARPHI \[500 MK I\] audiometer

Ear phones are used to test hearing by air conduction and a small vibrator placed over the mastoid is used test hearing by bone conduction. All audiometers incorporate a calibration circuit, which allows the output sound level to be set at each frequency. The signals presented to the subject by an audiometer are characterized by its frequency, sound pressure level and wave form which are all controlled.\[[@CIT13]\]

Methodology {#sec2-10}
-----------

### Protocol {#sec3-2}

All the subjects included in this study are given a prepared questionnaire to answer. This questionnaire was designed to reveal the patients\' assessment of hearing ability.

An assessment of the hearings status using a pure tone audiometer \[ARPHI 500 MK 1\] is done.

Pure tone audiometry {#sec2-11}
--------------------

### Principle:\[[@CIT13]\] {#sec3-3}

An audiometer \[ARPHI 500 MK 1\] is an electronic device that produces pure tones, the intensity of which can be increased or decreased in 5-Db steps. Air conduction thresholds are measured for tones of 250, 500, 1000, 1500, 2000, 4000 6000 and 8000 Hertz. Bone conduction thresholds and measured for 250, 500, 1000, 1500, 2000, 4000 Hertz. The amount of intensity that has to be raised above the normal level is a measure of the degree of hearing impairment at that frequency. It is charted in form of a graph called the "audiogram." The thresholds of bone conduction are a measure of the cochlear function. The difference in the thresholds of air and bone conduction (A-B gap) is a measure of a degree of conductive deafness. The audiometer is so calibrated that hearing of a normal person, both of air and bone conduction is at 0 db and there is no A-B gap.

Methodology of pure tone audiometry {#sec2-12}
-----------------------------------

The method is based on American Society for Speech and Hearing Association \[ASHA\] 1978 guidelines for manual pure tone audiometry (PTA). Masked pure tone audiometry is done if there is a difference of more than 40 dB between air conduction threshold of the test ear and the bone conduction threshold of the opposite ear, or when the air bone gap of the poorer ear under test is more than 10 dB.

Statistical methods\[[@CIT14][@CIT15]\] {#sec2-13}
---------------------------------------

Student t test (unpaired and two tailed) has been used to find the significance of auditory thresholds (dB) between various categories of parameters. Analysis of variance \[ANOVA\] has been used to find the significance of auditory thresholds in different age groups. The effect size (d) has been used to find the effect of DM on auditory thresholds (dB).

Statistical software: {#sec2-14}
---------------------

The statistical soft ware namely SPSS 11.0 and Systat 8.0 were used for the analysis of the data and Microsoft Word and Microsoft Excel have been used to generate graphs, tables, etc.

Results {#sec1-3}
=======

Tables [1](#T0001){ref-type="table"} and Table [2](#T0002){ref-type="table"} show the age and sex distribution of the control group and the diabetics.

###### 

Age distribution of the control group and the diabetics

  Age in years   Controls     Cases
  -------------- ------------ ------------
  35--40         8 (19.51)    8 (19.51)
  41--45         8 (19.51)    8 (19.51)
  46--50         8 (19.51)    8 (19.51)
  51--55         17 (41.46)   17 (41.46)
  Total          41           41

###### 

Sex distribution of the control group and the diabetics

  Sex      Controls     Cases
  -------- ------------ ------------
  Male     16 (39.02)   16 (39.02)
  Female   25 (60.98)   25 (60.98)
  Total    41           41

Differences in the fasting blood sugar and post-prandial blood sugar level between the cases and controls were statistically significant at 1% as seen in [Table 3](#T0003){ref-type="table"}.

###### 

Blood glucose levels in cases and controls

  Sugar Parameters   Controls (Mean ± SD)   Cases (Mean ± SD)   Significance
  ------------------ ---------------------- ------------------- -------------------------------------------
  FBG                80.00 ± 9.29           164.93 ± 64.51      8.344[\*\*](#T000F1){ref-type="table-fn"}
  PPBG               109.29 ± 8.82          250.68 ± 92.02      9.794[\*\*](#T000F1){ref-type="table-fn"}

\+ Near significant, \*Significant at 5%,

Significant at 1%

As shown in [Table 4](#T0004){ref-type="table"}, there was a significant difference in the auditory thresholds at all frequencies from 250 Hz to 8000 Hz between type 2 diabetic subjects and control group and all the hyperglycemic subjects showed sensorineural hearing loss changes on audiogram. The effect size was large to very large. The controls, all had normal hearing thresholds, whereas the cases showed a gradual increase in hearing loss starting at 250 Hz and becoming pronounced as the frequency increased. This difference is highly statistically significant at 1% confidence interval.

###### 

Effect of diabetes mellitus on auditory thresholds in dB

  Frequency in Hz   Auditory Thresholds in dB (Mean ± SD): normal threshold is less than or equal to 25 db \[WHO\]   Effect size (d)                                                       
  ----------------- ------------------------------------------------------------------------------------------------ ----------------- ------- ------------------------------------------- ------
  At 250            21.59 ± 3.48                                                                                     29.33 ± 8.27      53.73   5.525[\*\*](#T000F2){ref-type="table-fn"}   1.21
  At 500            21.77 ± 3.37                                                                                     31.83 ± 6.85      58.26   8.444[\*\*](#T000F2){ref-type="table-fn"}   1.85
  At 1000           20.49 ± 3.76                                                                                     29.21 ± 8.88      53.88   5.789[\*\*](#T000F2){ref-type="table-fn"}   1.27
  At 1500           19.27 ± 4.65                                                                                     26.59 ± 8.32      62.76   4.913[\*\*](#T000F2){ref-type="table-fn"}   1.08
  At 2000           19.63 ± 3.64                                                                                     29.82 ± 8.78      53.52   6.886[\*\*](#T000F2){ref-type="table-fn"}   1.50
  At 3000           19.21 ± 4.62                                                                                     27.59 ± 8.65      61.13   5.468[\*\*](#T000F2){ref-type="table-fn"}   1.20
  At 4000           20.85 ± 4.62                                                                                     34.21 ± 9.96      52.90   7.951[\*\*](#T000F2){ref-type="table-fn"}   1.70
  At 6000           20.37 ± 3.69                                                                                     36.46 ± 10.98     48.92   8.897[\*\*](#T000F2){ref-type="table-fn"}   1.95
  At 8000           20.12 ± 3.75                                                                                     35.24 ± 12.39     47.25   7.476[\*\*](#T000F2){ref-type="table-fn"}   1.64

+Near significant, \*Significant at 5%,

Significant at 1%

As shown in [Table 5](#T0005){ref-type="table"}, there was no statistically significant difference in auditory thresholds among type 2 diabetic patients and control group when analyzed according to their age groups, yet all type 2 diabetic patients\' auditory thresholds were higher than the control groups\' thresholds.

###### 

Auditory thresholds (Db) in age-wise subgroups of diabetics

  Frequency (Hz)   Group           Auditory Thresholds in dB (Mean ± SD)   Significance ANOVA                                                            
  ---------------- --------------- --------------------------------------- -------------------- --------------- ---------------------------------------- -------------------------------------------
  250              Control         18.75±4.43                              21.88 ± 2.22         20.63 ± 4.58    23.24 ± 1.71                             0.015[\*](#T000F3){ref-type="table-fn"}
  Case             23.21 ± 6.07    26.56 ±7.19                             31.25 ± 6.94         30.88 ± 7.44    0.073[+](#T000F4){ref-type="table-fn"}   
  500              Control         19.38 ± 3.47                            20.31 ± 2.48         21.56 ± 4.22    23.68 ± 2.18                             0.007[\*\*](#T000F5){ref-type="table-fn"}
  Case             27.55 ± 7.32    29.38 ± 6.38                            35.63 ± 6.65         33.24 ± 5.91    0.053[+](#T000F4){ref-type="table-fn"}   
  1000             Control         183.43 ± 4.21                           19.69 ±3.88          20.00 ± 5.17    22.06 ± 2.02                             0.115
  Case             26.25 ± 11.41   25.93 ± 7.89                            32.19 ± 9.01         30.74 ± 7.79    0.347                                    
  1500             Control         15.94 ± 4.81                            17.19 ± 5.08         19.38 ± 5.13    21.76 ± 2.62                             0.009[\*\*](#T000F5){ref-type="table-fn"}
  Case             21.87 ± 7.76    25.63 ± 9.61                            28.44±8.65           28.38±7.55      0.284                                    
  2000             Control         18.13 ± 5.13                            17.81 ± 2.48         19.69 ± 3.88    21.17 ± 2.67                             0.088[+](#T000F4){ref-type="table-fn"}
  Case             25.94 ± 9.06    27.19 ± 9.58                            30.31 ± 8.28         32.65 ± 8.07    0.256                                    
  3000             Control         15.62 ± 3.47                            16.88 ± 5.47         19.69 ± 3.64    21.17 ± 3.62                             0.004[\*\*](#T000F5){ref-type="table-fn"}
  Case             23.13 ± 10.06   26.87 ± 9.33                            29.06±6.80           29.32±8.36      0.388                                    
  4000             Control         19.69 ± 5.58                            19.06 ± 3.99         20.63 ± 4.58    22.35 ± 2.57                             0.208
  Case             31.87 ± 13.01   33.13 ± 8.43                            34.69 ± 10.13        35.59 ± 9.62    0.842                                    
  6000             Control         18.44 ± 3.99                            20.31 ± 4.89         19.06±3.76      21.91±2.26                               0.099[+](#T000F4){ref-type="table-fn"}
  Case             31.25 ± 12.88   37.50 ± 10.77                           39.06 ± 11.25        37.21 ± 10.23   0.509                                    
  8000             Control         17.50 ± 4.63                            20.00 ± 4.82         18.75 ± 2.99    22.06 ± 1.82                             0.017[\*](#T000F3){ref-type="table-fn"}
  Case             30.31 ± 15.37   39.06 ± 12.24                           38.13 ± 12.16        34.41 ± 11.23   0.484                                    

Near Significant,

Significant at 5%,

Significant at 1%

As shown in [Table 6](#T0006){ref-type="table"}, from a frequency of 250 Hz to 8000 Hz, there was a significant difference between diabetic type 2 patients with good control of their blood sugars \[HbA1c values between 6% and 8%\] versus type 2 diabetic patients with poor control \[HbA1c values greater than 8%\]. The number of patients in the good control group was 20 and in the poor control group was 21. The significance levels are at 1%.

###### 

Auditory thresholds (db) in HbA1C-wise subgroups of diabetics

  Frequency (Hz)   Auditory Thresholds (dB) (Mean ± SD)   *P* value by student t   
  ---------------- -------------------------------------- ------------------------ -------------------------------------------
  250              25.75 ± 5.91                           31.62 ± 7.18             0.010[\*\*](#T000F6){ref-type="table-fn"}
  500              29.50 ± 4.97                           34.44 ± 7.55             0.021[\*\*](#T000F6){ref-type="table-fn"}
  1000             26.13 ± 6.31                           32.78 ± 9.69             0.016[\*\*](#T000F6){ref-type="table-fn"}
  1500             23.38 ± 5.27                           30.00 ± 9.19             0.009[\*\*](#T000F6){ref-type="table-fn"}
  2000             26.38 ± 7.28                           33.78 ± 8.41             0.006[\*\*](#T000F6){ref-type="table-fn"}
  3000             23.88 ± 6.76                           32.42 ± 7.89             0.001[\*\*](#T000F6){ref-type="table-fn"}
  4000             30.63 ± 8.91                           39.44 ± 8.93             0.004[\*\*](#T000F6){ref-type="table-fn"}
  6000             32.25 ± 9.79                           42.08 ± 10.62            0.005[\*\*](#T000F6){ref-type="table-fn"}
  8000             29.88 ± 11.02                          41.94 ± 11.59            0.002[\*\*](#T000F6){ref-type="table-fn"}

+Near significant, \*Significant at 5%,

Significant at 1%

[Table 7](#T0007){ref-type="table"} shows that there was no significant difference in the hearing thresholds between patients with short duration of type 2 diabetes \[less than 10 years\] versus long duration \[greater than 10 years\].

###### 

Auditory thresholds (db) in duration-wise subgroups of diabetics

  Frequency   Auditory thresholds (dB) (Mean ± SD)   *P* value by student t   
  ----------- -------------------------------------- ------------------------ ----------------------------------------
  250         27.73 ± 7.21                           33.57 ± 7.34             0.060[+](#T000F7){ref-type="table-fn"}
  500         31.10 ± 7.05                           35.36 ± 4.66             0.136
  1000        28.60 ± 8.90                           32.14 ± 8.83             0.343
  1500        26.25 ± 8.19                           28.21 ± 9.43             0.576
  2000        29.56 ± 8.36                           31.07 ± 11.07            0.682
  3000        27.31 ± 8.42                           28.93 ± 10.29            0.658
  4000        33.97 ± 9.28                           35.36 ± 13.65            0.742
  6000        35.36 ± 10.32                          40.36 ± 14.03            0.309
  8000        34.71 ± 11.99                          37.86 ± 14.96            0.547

Near significant,

\*Significant at 5%, \*\*Significant at 1%

[Table 8](#T0008){ref-type="table"} shows that there is a trend towards a difference which is noted at higher frequencies (6000 Hz and 8000 Hz) when the effect of fasting blood sugar levels on auditory thresholds is considered.

###### 

Auditory thresholds (db) in FBS-wise subdivisions of diabetics

  Frequency (Hz)   Auditory thresholds in dB (Mean ± SD) in different FBS levels   Significance ANOVA                                   
  ---------------- --------------------------------------------------------------- -------------------- --------------- --------------- ----------------------------------------
  250              29.00 ± 5.76                                                    26.83 ± 8.58         29.72 ± 7.12    30.45 ± 7.23    0.651
  500              29.00 ± 3.79                                                    30.67 ± 6.91         32.50 ± 8.82    34.09 ± 5.73    0.475
  1000             29.00 ± 8.22                                                    26.33 ± 8.65         31.00 ± 10.68   31.59 ± 7.69    0.441
  1500             27.00 ± 4.81                                                    23.50 ± 7.12         29.25 ± 10.54   28.18 ± 8.52    0.329
  2000             31.00 ± 6.02                                                    25.66 ± 7.76         32.75 ± 8.37    32.77 ± 10.09   0.138
  3000             26.00 ± 2.82                                                    23.83 ± 9.72         30.10 ± 8.22    31.14 ± 7.77    0.125
  4000             32.50 ± 7.29                                                    30.17 ± 9.84         38.00 ± 9.92    37.04 ± 10.11   0.175
  6000             32.00 ± 9.46                                                    31.83 ± 10.06        39.25 ± 8.97    42.27 ± 11.96   0.059[+](#T000F8){ref-type="table-fn"}
  8000             33.00 ± 11.51                                                   29.50 ± 11.73        39.25 ± 11.55   40.45 ± 12.29   0.090[+](#T000F8){ref-type="table-fn"}

Near significant,

\*Significant at 5%, \*\*Significant at 1%

[Table 9](#T0009){ref-type="table"} shows that there is a 5% significant difference at 3000, 4000, and 8000 Hz and a 1% significant difference at 6000 Hz when the effect of post prandial blood sugar levels on the auditory thresholds is considered.

###### 

Auditory thresholds (db) in PPBS-wise subdivisions of diabetics

  Frequency (Hz)   Auditory thresholds in dB (Mean ± SD) in different PPBS levels   Significance ANOVA                                   
  ---------------- ---------------------------------------------------------------- -------------------- --------------- --------------- --------------------------------------------
  250              26.00 ± 6.93                                                     30.36 ± 7.81         28.21 ± 6.07    34.37 ± 8.26    0.175
  500              29.50 ± 5.61                                                     32.66 ± 7.68         32.81 ± 7.49    35.63 ± 6.25    0.351
  1000             26.00 ± 7.12                                                     30.00 ± 10.05        31.25 ± 8.35    34.38 ± 10.68   0.285
  1500             23.00 ± 5.84                                                     28.75 ± 9.54         27.19 ± 7.84    31.25 ± 10.51   0.169
  2000             25.83 ± 6.66                                                     31.96 ± 8.73         30.63 ± 9.04    35.63 ± 11.96   0.118
  3000             22.83 ± 6.81                                                     29.89 ± 8.94         28.13 ± 8.10    36.25 ± 6.61    0.017[\*](#T000F9){ref-type="table-fn"}
  4000             30.17 ± 9.75                                                     35.89 ± 9.18         33.75 ± 9.75    44.38 ± 8.75    0.014[\*](#T000F9){ref-type="table-fn"}
  6000             30.83 ± 10.34                                                    38.75 ± 8.86         35.93 ± 10.60   50.63 ± 7.47    0.006[\*\*](#T000F10){ref-type="table-fn"}
  8000             28.67 ± 12.20                                                    38.39 ± 10.59        35.63 ± 11.39   48.13 ± 8.98    0.018[\*](#T000F9){ref-type="table-fn"}

+Near significant,

Significant at 5%,

Significant at 1%

Discussion {#sec1-4}
==========

The relationship between diabetes mellitus and hearing loss is controversial, primarily because the pathogenic mechanism remains obscure. This is a case control study investigating this relationship using pure tone audiometer.

Diabetes has been shown to affect hearing loss by many studies. Many have tried to identify the cause, and based on their conclusions, the probable mechanisms are microangiopathy of the inner ear, neuropathy of the cochlear nerve, a combination of both, outer hair dysfunction and disruption of endolymphatic potential.

This study demonstrates a significant hearing loss in diabetes in all the frequencies tested. This could be explained by microangiopathy of the vessels to the inner ear as proposed by Wackym.\[[@CIT16]\]

The effect of age on auditory thresholds in diabetic subjects was found to be clinically and statistically insignificant. Kakarlapudi\[[@CIT4]\] and Dalton\[[@CIT8]\] both showed similar findings in their study, but Taylor and Irwin\[[@CIT3]\] found a correlation between hearing levels and age of the subjects in the diabetic group and concluded that any hearing loss due to diabetes will be additional to that due to age alone. Similar conclusions were drawn by Axelson.\[[@CIT5]\]

Lack of glycemic control shows a positive correlation with extent of hearing loss when compared to those diabetics with good glycemic control. This is noted in all the frequencies tested. Both Kurien\[[@CIT7]\] and Lasisi\[[@CIT2]\] show similar findings. A possible mechanism to explain this observation could be the cumulative effects of advanced glycation end products on the inner ear. High post-prandial blood sugar levels cause a significant alteration in high frequency hearing thresholds in diabetics. Damage to outer hair cells by sustained hyperglycemia has been noted in animal studies.\[[@CIT6][@CIT17]--[@CIT19]\] Currently, outer hair cell function in diabetes is an area of intense research activity.

The present study supports the hypothesis that duration of diabetes does not alter hearing thresholds.\[[@CIT3][@CIT5][@CIT7][@CIT8]\] It is now being understood that the degree of hypergylcemia and the duration of uncontrolled hyperglycemia is more important than the duration of the disease itself.

Screening of all patients with diabetes for hearing loss in a longitudinal study may provide a clearer understanding of the relationship between diabetes and hearing loss. It is the intention of the author to continue with such a study and evaluate the function of outer hair cells in a well selected diabetic population in India.

Conclusions {#sec1-5}
===========

In this study, the auditory acuity of hyperglycemic and normoglycemic subjects were studied. The variables influencing the auditory acuity were statistically analyzed which revealed the following: Diabetes mellitus type 2 raises auditory threshold in all frequencies between 250 Hz and 8000 Hz in all age groups in this study.Patients with poor control \[HbA1c greater than 8%\] of their glycemic status have raised auditory thresholds.The duration of diabetes does not affect auditory thresholds significantly in this study.There was no association between the diabetic age-wise subgroups and their corresponding auditory thresholds. But in the age-wise subgroups in controls, there was an association between the subgroups and auditory thresholds. But the auditory thresholds were still within the normal limits.

These results which show the effect of hyperglycemia on auditory acuity may be explained by diabetic microangiopathy of the inner ear.

Summary {#sec1-6}
=======

The relationship between diabetes and hearing loss is controversial. The present study was undertaken to better understand the disease and its influence on hearing acuity. The study involved determination of the auditory thresholds in two groups of subjects namely, hyperglycemic and normoglycemic subjects. The hearing thresholds were evaluated in both the groups using a pure tone audiometer (ARPHI 500 MK 1). The glycemic status (FBS, PPBS) and the degree of the glycemic control (HbA1C) of the hyperglycemic subjects were also assessed. The results obtained were then subjected to statistical treatment.

The results showed that the hyperglycemic subjects were significantly hearing impaired than the normoglycemic group. This hearing impairment was noted in all the frequencies tested. The glycemic status and the degree of glycemic control played a significant role in reducing the auditory acuity of the hyperglycemic subjects, while the duration of hyperglycemia and the age of the subjects did not influence the hearing acuity.
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